Major drug-maker promises to limit price increases
Merck joined fellow pharmaceutical giants Novartis and Pfizer on Thursday in pledging to limit drug price increases in the United States. Merck said it's cutting the price of Zepatier, a drug that treats hepatitis C, by 60% and reducing the price of six other medications by 10% each. The company also said it will not raise the average price of the drugs it sells beyond the annual rate of inflation in the United States and will continue to "evaluate our portfolio to look for opportunities to further reduce costs."